Prevalence of vitamin B12 depletion and deficiency in Liechtenstein

Koenig, Victoria; Stanga, Zeno; Zerlauth, Manfred; Bernasconi, Luca; Risch, Martin; Huber, Andreas; Risch, Lorenz (2014). Prevalence of vitamin B12 depletion and deficiency in Liechtenstein. Public health nutrition, 17(2), pp. 241-247. Cambridge: Cambridge University Press 10.1017/S1368980012005289

[img]
Preview
Text
download.pdf - Published Version
Available under License Publisher holds Copyright.

Download (207kB) | Preview

OBJECTIVE: Data about vitamin B12 (B12) deficiency in the general population are scarce. The present study was performed to determine the prevalence of B12 deficiency in the general population of the Principality of Liechtenstein, as well as to identify sub-populations potentially at high risk. DESIGN: Retrospective study. SETTING: Ambulatory setting, population of the Principality of Liechtenstein. SUBJECTS: Seven thousand four hundred and twenty-four patients seeking medical attention whose serum samples were referred for routine work-up in an ambulatory setting were consecutively enrolled. Serum total B12 was determined in all patients in this cohort. In addition, for a subgroup of 1328 patients, serum holotranscobalamin was also measured. Prevalence of B12 deficiency was calculated. Further, multivariate logistical regression models were applied to identify covariates independently associated with B12 deficiency and depletion. RESULTS: Nearly 8 % of the general population was suffering from either B12 depletion or deficiency. The ratio between B12 depletion and deficiency was 2:1 for all age ranges. Pathological changes were detected predominantly in older people. Female gender was a significant predictor of B12 depletion. In the cohort, nearly 40 % exhibited either depletion or deficiency of B12. CONCLUSIONS: B12 depletion and deficiency are common in Liechtenstein, a Central European country. The measurement of biochemical markers represents a cost-efficient and valid assessment of the B12 state. When a deficiency of B12 is diagnosed at an early stage, many cases can be treated or prevented, with beneficial effects on individual outcomes and subsequent potential reductions in health-care costs.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine

UniBE Contributor:

Stanga, Zeno

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1368-9800

Publisher:

Cambridge University Press

Language:

English

Submitter:

Jacques Donzé

Date Deposited:

04 Oct 2013 14:36

Last Modified:

02 Mar 2023 23:21

Publisher DOI:

10.1017/S1368980012005289

PubMed ID:

23237337

BORIS DOI:

10.7892/boris.14438

URI:

https://boris.unibe.ch/id/eprint/14438 (FactScience: 221415)

Actions (login required)

Edit item Edit item
Provide Feedback